The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): Beneficial or detrimental to endothelial barrier?

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3132-3146

  Bogatcheva, Natalia V ^a   Zemskova, Marina A ^a   Poirier, Christophe ^a   Mirzapoiazova, Tamara ^b   Kolosova, Irina ^c   Bresnick, Anne R ^d   Verin, Alexander D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; LIPOPOLYSACCHARIDE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; RHO KINASE; RHO KINASE 1; RHO KINASE 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PERMEABILIZATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE;

AMIDES; CALCIUM; CAPILLARY PERMEABILITY; CELLS, CULTURED; CYCLIC AMP; DEXTRANS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTOXINS; FLUORESCEIN-5-ISOTHIOCYANATE; FORSKOLIN; HUMANS; LUNG; MICROVESSELS; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PYRIDINES; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 80053166480     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22669     Document Type: Article

References (47)

1. Bindewald K, Gunduz D, Hartel F, Peters SC, Rodewald C, Nau S, Schafer M, Neumann J, Piper HM, Noll T. 2004. Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol 287: C1246-C1255.
2. Bogatcheva NV, Verin AD. 2008. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76: 202-207.
3. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD. 2009. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 221: 750-759.
4. Bresnick AR, Wolff-Long VL, Baumann O, Pollard TD. 1995. Phosphorylation on threonine-18 of the regulatory light chain dissociates the ATPase and motor properties of smooth muscle myosin II. Biochemistry 34: 12576-12583.
5. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. 2002. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 16: 583-585.
6. Csortos C, Kolosova I, Verin AD. 2007. Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family. Am J Physiol Lung Cell Mol Physiol 293: L843-L854.
7. da Silva-Santos JE, Chiao CW, Leite R, Webb RC. 2009. The Rho-A/Rho-kinase pathway is up-regulated but remains inhibited by cyclic guanosine monophosphate-dependent mechanisms during endotoxemia in small mesenteric arteries. Crit Care Med 37: 1716-1723.
8. Essler M, Staddon JM, Weber PC, Aepfelbacher M. 2000. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 164: 6543-6549.
9. Eutamene H, Theodorou V, Schmidlin F, Tondereau V, Garcia-Villar R, Salvador-Cartier C, Chovet M, Bertrand C, Bueno L. 2005. LPS-induced lung inflammation is linked to increased epithelial permeability: Role of MLCK. Eur Respir J 25: 789-796.
10. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu A, Kaibuchi K, Hartshorne DJ, Nakano T. 1999. Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 274: 3744-3752.
11. Finigan JH, Boueiz A, Wilkinson E, Damico R, Skirball J, Pae HH, Damarla M, Hasan E, Pearse DB, Reddy SP, Grigoryev DN, Cheadle C, Esmon CT, Garcia JG, Hassoun PM. 2009. Activated protein C protects against ventilator-induced pulmonary capillary leak. Am J Physiol Lung Cell Mol Physiol 296: L1002-L1011.
12. Fukata Y, Amano M, Kaibuchi K. 2001. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39.
13. Garcia JG, Lazar V, Gilbert-McClain LI, Gallagher PJ, Verin AD. 1997. Myosin light chain kinase in endothelium: Molecular cloning and regulation. Am J Respir Cell Mol Biol 16: 489-494.
14. Goeckeler ZM, Wysolmerski RB. 1995. Myosin light chain kinase-regulated endothelial cell contraction: The relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 130: 613-627.
15. Herring BP, El-Mounayri O, Gallagher PJ, Yin F, Zhou J. 2006. Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am J Physiol Cell Physiol 291: C817-C827.
16. Ikebe M, Hartshorne DJ. 1985. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260: 10027-10031.
17. Ikebe M, Koretz J, Hartshorne DJ. 1988. Effects of phosphorylation of light chain residues threonine 18 and serine 19 on the properties and conformation of smooth muscle myosin. J Biol Chem 263: 6432-6437.
18. Itoh K, Hara T, Shibata N. 1992. Diphosphorylation of platelet myosin by myosin light chain kinase. Biochim Biophys Acta 1133: 286-292.
19. Jacobson JR, Garcia JG. 2007. Novel therapies for microvascular permeability in sepsis. Curr Drug Targets 8: 509-514.
20. Kamm KE, Stull JT. 2001. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276: 4527-4530.
21. Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JG, Verin AD. 2008. Protective effect of purinergic agonist ATPgammaS against acute lung injury. Am J Physiol Lung Cell Mol Physiol 294: L319-L324.
22. Komarova Y, Malik AB. 2010. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72: 463-493.
23. Kooistra MR, Corada M, Dejana E, Bos JL. 2005. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579: 4966-4972.
24. Lorenowicz MJ, Fernandez-Borja M, Hordijk PL. 2007. cAMP signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 27: 1014-1022.
25. Lundblad C, Bentzer P, Grande PO. 2004. The permeability-reducing effects of prostacyclin and inhibition of Rho kinase do not counteract endotoxin-induced increase in permeability in cat skeletal muscle. Microvasc Res 68: 286-294.
26. Martin GS, Bernard GR. 2002. Management of respiratory dysfunction in patients with severe sepsis. In: Vincent J-L, Carlet J, Opal SM, editors. The sepsis text. Boston Dordrecht London: Kluwer Academic Publishers. pp 455-477.
27. Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
28. Matsumura F, Hartshorne DJ. 2008. Myosin phosphatase target subunit: Many roles in cell function. Biochem Biophys Res Commun 369: 149-156.
29. Mirzapoiazova T, Moitra J, Moreno-Vinasco L, Sammani S, Turner JR, Chiang ET, Evenoski C, Wang T, Singleton PA, Huang Y, Lussier YA, Watterson DM, Dudek SM, Garcia JG. 2011. The non muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury. Am J Respir Cell Mol Biol 44: 40-52.
30. Mong PY, Wang Q. 2009. Activation of Rho kinase isoforms in lung endothelial cells during inflammation. J Immunol 182: 2385-2394.
31. Moriez R, Salvador-Cartier C, Theodorou V, Fioramonti J, Eutamene H, Bueno L. 2005. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am J Pathol 167: 1071-1079.
32. Murray AJ. 2008. Pharmacological PKA inhibition: All may not be what it seems. Sci Signal 1: re4.
33. Nichols RJ, Dzamko N, Hutti JE, Cantley LC, Deak M, Moran J, Bamborough P, Reith AD, Alessi DR. 2009. Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem J 424: 47-60.
34. Nishikawa M, de Lanerolle P, Lincoln TM, Adelstein RS. 1984. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem 259: 8429-8436.
35. Opal SM. 2007. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297: 365-377.
36. Qiao J, Huang F, Lum H. 2003. PKA inhibits RhoA activation: A protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284: L972-L980.
37. Samarin SN, Ivanov AI, Flatau G, Parkos CA, Nusrat A. 2007. Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell 18: 3429-3439.
38. Schlegel N, Baumer Y, Drenckhahn D, Waschke J. 2009. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro. Crit Care Med 37: 1735-1743.
39. Tasaka S, Koh H, Yamada W, Shimizu M, Ogawa Y, Hasegawa N, Yamaguchi K, Ishii Y, Richer SE, Doerschuk CM, Ishizaka A. 2005. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. Am J Respir Cell Mol Biol 32: 504-510.
40. Uchimura T, Fumoto K, Yamamoto Y, Ueda K, Hosoya H. 2002. Spatial localization of mono-and diphosphorylated myosin II regulatory light chain at the leading edge of motile HeLa cells. Cell Struct Funct 27: 479-486.
41. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. 2007. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 27: 2332-2339.
42. Verin AD, Cooke C, Herenyiova M, Patterson CE, Garcia JG. 1998a. Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses. Am J Physiol 275: L788-L799.
43. Verin AD, Lazar V, Torry RJ, Labarrere CA, Patterson CE, Garcia JG. 1998b. Expression of a novel high molecular-weight myosin light chain kinase in endothelium. Am J Respir Cell Mol Biol 19: 758-766.
44. Verin AD, Birukova A, Wang P, Liu F, Becker P, Birukov K, Garcia JG. 2001. Microtubule disassembly increases endothelial cell barrier dysfunction: Role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 281: L565-L574.
45. Wainwright MS, Rossi J, Schavocky J, Crawford S, Steinhorn D, Velentza AV, Zasadzki M, Shirinsky V, Jia Y, Haiech J, Van Eldik LJ, Watterson DM. 2003. Protein kinase involved in lung injury susceptibility: Evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci USA 100: 6233-6238.
46. Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
47. Watanabe T, Hosoya H, Yonemura S. 2007. Regulation of myosin II dynamics by phosphorylation and dephosphorylation of its light chain in epithelial cells. Mol Biol Cell 18: 605-616.